SCHEMBL534830

SCHEMBL534830

Nc1cc(O)ccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31272965 1.00 — —
Hydrochloric Acid SCHEMBL11490972 0.97 CA1 (0.95) —
SCHEMBL33714 0.79 — —
Hydrochloric Acid SCHEMBL249529 0.77 ESR2 (0.65) —
Hydrochloric Acid SCHEMBL2461057 0.75 CA12 (0.59) —
SCHEMBL29458034 0.75 — —
SCHEMBL29374280 0.75 — —
SCHEMBL543834 0.75 — —
SCHEMBL224868 0.75 — —
SCHEMBL1043548 0.72 CA14 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 517 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108670871-A A kind of hair dye and its application method 花安堂生物科技集团有限公司 2018-10-19 — — CN claimed
CN-104876859-B Pyrrole worm is grand and preparation method thereof 常州佳灵药业有限公司 2018-03-13 — — CN claimed
CN-105916482-A Gradual hair color compositions and methods of use thereof 酷姆国际公司 2016-08-31 — — CN claimed
CN-104876859-A Fluazuron and preparing method thereof Changzhou jialing medicine industry co ltd 2015-09-02 — — CN claimed
US-9017726-B2 Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-04-28 — — US claimed
US-8586020-B2 Poly(organophosphazene) composition for biomaterials KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-11-19 — — US claimed
US-20130004455-A1 POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-01-03 — — US claimed
EP-2540764-A2 Poly(organophosphazene) composition for biomaterials Korea Institute of Science and Technology (KR) 2013-01-02 — — EP claimed
US-8313771-B2 Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-11-20 — — US claimed
US-8288552-B2 Dihydropyridone amidesas P2X7 modulators ROCHE PALO ALTO LLC (US) 2012-10-16 — — US claimed
US-20120121517-A1 BIODEGRADABLE AND THERMOSENSITIVE POLY(ORGANOPHOSPHAZENE)-SUPERPARAMAGNETIC NANOPARTICLE COMPLEX, PREPARATION METHOD AND USE THEREOF Korean Institute of Science and Technology of Seoul, Republic of Korea 2012-05-17 — — US claimed
US-20100297155-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS-LINK, PREPARATION METHOD THEREOF AND USE THEREOF DECA ITALIA S.R.L. (IT) 2010-11-25 — — US claimed
EP-2155806-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF Korea Institute of Science and Technology (KR) 2010-02-24 — — EP claimed
CN-101565381-A Method for preparing 2-alkoxy-4-amino-5-chlorobenzoic acid CHONGQING ENSKY CHEMICAL CO LT (CN) 2009-10-28 — — CN claimed
WO-2008153278-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-12-18 — — WO claimed
CN-1882307-A Method for dyeing fibres containing keratine HENKEL KGAA (DE) 2006-12-20 — — CN claimed
CN-1166354-C Dyes �����ɷ� 2004-09-15 — — CN claimed
CN-1265578-A Dyes HENKEL KGAA (DE) 2000-09-06 — — CN claimed
CN-1072590-A Oxidative hair dye composition and people's process for dyeing keratin fibers BRISTOL MYERS SQUIBB CO (US) 1993-06-02 — — CN claimed
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
US-12319702-B2 Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors DART NEUROSCIENCE, LLC (US) 2025-06-03 — — US disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
US-20240199643-A1 SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS DART NEUROSCIENCE LLC (US) 2024-06-20 — — US disclosed
EP-3652180-B1 SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS DART NEUROSCIENCE LLC (US) 2023-11-29 — — EP disclosed
CN-116514868-A Sulfonamide compound for treatment, preparation method and application thereof 华创合成制药股份有限公司 2023-08-01 — — CN disclosed
US-11685745-B2 Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors DART NEUROSCIENCE, LLC (US) 2023-06-27 — — US disclosed
US-20230061891-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2023-03-02 — — US disclosed
US-20230061891-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2023-03-02 — — US disclosed
US-20220387602-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE NOVARTIS AG (CH) 2022-12-08 — — US disclosed
US-20220267351-A1 SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS DART NEUROSCIENCE, LLC 2022-08-25 — — US disclosed
EP-4031247-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE Novartis AG (CH) 2022-07-27 — — EP disclosed
CN-114521196-A Bifunctional group degradation agent and use method thereof 诺华股份有限公司 2022-05-20 — — CN disclosed
US-20210317137-A1 NEAR-INFRARED NERVE-SPARING FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-10-14 — — US disclosed
US-11111229-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2021-09-07 — — US disclosed
US-11111229-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2021-09-07 — — US disclosed
US-20210236657-A1 NERVE-SPECIFIC FLUOROPHORE FORMULATIONS FOR DIRECT AND SYSTEMIC ADMINISTRATION OREGON HEALTH & SCIENCE UNIVERSITY (US) 2021-08-05 — — US disclosed
WO-2021083167-A1 SUBSTITUTED HETEROCYCLIC FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 劲方医药科技(上海)有限公司 2021-05-06 — — WO disclosed
EP-3799872-A1 TETRAHYDROQUINOLINE DERIVATIVES FOR USE AS BET INHIBITORS Forma Therapeutics, Inc. (US) 2021-04-07 — — EP disclosed
EP-3799872-A1 TETRAHYDROQUINOLINE DERIVATIVES FOR USE AS BET INHIBITORS Forma Therapeutics, Inc. (US) 2021-04-07 — — EP disclosed
WO-2021053495-A1 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE NOVARTIS AG (CH) 2021-03-25 — — WO disclosed
EP-3071203-B1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS INC (US) 2020-12-23 — — EP disclosed
EP-3071203-B1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS INC (US) 2020-12-23 — — EP disclosed
US-20200369642-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2020-11-26 — — US disclosed
US-20200369642-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2020-11-26 — — US disclosed
CN-106795117-B Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2020-06-26 — — CN disclosed
EP-3652180-A1 SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS Dart NeuroScience LLC (US) 2020-05-20 — — EP disclosed
US-10611750-B2 Tetrahydroquinoline compositions as bet bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2020-04-07 — — US disclosed
WO-2020023911-A2 NEAR-INFRARED NERVE-SPARING FLUOROPHORES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2020-01-30 — — WO disclosed
CN-110627770-A Tetrahydroquinoline compositions as BET bromodomain inhibitors 福马疗法公司 2019-12-31 — — CN disclosed
US-10464926-B2 Heterobicyclic compounds and their use for the treatment of tuberculosis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2019-11-05 — — US disclosed
CN-105934246-B Tetrahydroquinoline compositions as BET bromodomain inhibitors 福马疗法公司 2019-10-22 — — CN disclosed
US-10407417-B2 Substituted anilines as CCR(4) antagonists CHEMOCENTRYX, INC. (US) 2019-09-10 — — US disclosed
CN-110156712-A It is a kind of to utilize aromatic nitration by-product synthesis benzoxazoles class compound and application 邵玉田 2019-08-23 — — CN disclosed
CN-103764111-B Dye composite comprising cationic para-aminophenol oxidation base 莱雅公司 2019-07-12 — — CN disclosed
US-10336722-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2019-07-02 — — US disclosed
US-10336722-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2019-07-02 — — US disclosed
EP-3186240-B1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2019-06-12 — — EP disclosed
CN-109789067-A Oxidizing agent composition containing surfactant in the packaging formed by the foil containing barrier layer 汉高股份有限及两合公司 2019-05-21 — — CN disclosed
CN-109715518-A \" oxidizing agent composition containing surfactant in the packaging made of barrier tunic IV \ 汉高股份有限及两合公司 2019-05-03 — — CN disclosed
US-20190127347-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2019-05-02 — — US disclosed
US-20190127347-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2019-05-02 — — US disclosed
CN-105828881-B Reduce the oxidation dye of hair damages 汉高股份有限及两合公司 2019-04-30 — — CN disclosed
CN-109689164-A Thickened formulation containing oxidant in the packaging formed by the foil containing barrier layer 汉高股份有限及两合公司 2019-04-26 — — CN disclosed
CN-109689018-A Oxidant composition comprising a surfactant in a package consisting of a barrier layer film III 汉高股份有限及两合公司 2019-04-26 — — CN disclosed
CN-109689163-A Thickened oxidizing agent-containing formulations in packages consisting of a barrier layer film II 汉高股份有限及两合公司 2019-04-26 — — CN disclosed
CN-109689162-A Oily oxidant composition in package made of barrier film 汉高股份有限及两合公司 2019-04-26 — — CN disclosed
CN-109689361-A Oxidizing agent composition containing surfactant in package composed of barrier layer film II 汉高股份有限及两合公司 2019-04-26 — — CN disclosed
CN-105555251-B The multicomponent packaging unit of the heat-tinting for keratin fiber with reduced ammonia odor 汉高股份有限及两合公司 2019-04-02 — — CN disclosed
WO-2019014305-A1 SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS AS PDE7 INHIBITORS DART NEUROSCIENCE, LLC (US) 2019-01-17 — — WO disclosed
US-20180312488-A1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-11-01 — — US disclosed
CN-108670871-A A kind of hair dye and its application method 花安堂生物科技集团有限公司 2018-10-19 — — CN disclosed
CN-108472232-A The composition for including p-phenylenediamine type oxidation base and 2- amino -5- ethyl -phenol colour couplers for colored hair 莱雅公司 2018-08-31 — — CN disclosed
CN-108472235-A The composition for including heterocycle oxidation base and 2- amino -5- ethyl -phenol colour couplers for hair dyeing 莱雅公司 2018-08-31 — — CN disclosed
US-10053430-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORP. (US) 2018-08-21 — — US disclosed
US-10053446-B2 Heterobicyclic compounds and their use for the treatment of tuberculosis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-08-21 — — US disclosed
CN-108366928-A The composition comprising oxidation base, 2- amino -5- ethyl -phenols colour coupler and fatty material for hair dyeing 莱雅公司 2018-08-03 — — CN disclosed
US-20180215766-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2018-08-02 — — US disclosed
US-20180215766-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2018-08-02 — — US disclosed
US-20180215766-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2018-08-02 — — US disclosed
CN-104853735-B For the autoxidizable reduction of the reagent of the oxidising dyeing and/or blast of keratin fiber 汉高股份有限及两合公司 2018-06-08 — — CN disclosed
CN-108042396-A A kind of double-formulation composition for hair dying and preparation method thereof 花安堂生物科技集团有限公司 2018-05-18 — — CN disclosed
CN-106336385-B The synthetic method of Yi Zhong Evil humulones 江苏丰华化学工业有限公司 2018-05-11 — — CN disclosed
CN-104768617-B Method for straightening and dyeing hair 花王株式会社 2018-03-20 — — CN disclosed
CN-104876859-B Pyrrole worm is grand and preparation method thereof 常州佳灵药业有限公司 2018-03-13 — — CN disclosed
EP-2268623-B9 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2018-02-28 — — EP disclosed
EP-3004097-B1 KINASE INHIBITORS CHIESI FARM SPA (IT) 2018-01-17 — — EP disclosed
CN-107501099-A The adjusting control agent of ATP combination cassette transporters 沃泰克斯药物股份有限公司 2017-12-22 — — CN disclosed
CN-107428747-A Substituted pyridobenzodiazepine ketone derivative and use thereof 拜耳制药股份公司 2017-12-01 — — CN disclosed
EP-3233199-A1 METHOD FOR MAINTAINING THE COLOUR OF DYED AND/OR HIGHLIGHTED KERATIN FIBRES Henkel AG & Co. KGaA (DE) 2017-10-25 — — EP disclosed
US-20170298029-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2017-10-19 — — US disclosed
EP-3223821-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2017-10-04 — — EP disclosed
CN-104788328-B The adjusting control agent of ATP combination cassette transporters 沃泰克斯药物股份有限公司 2017-09-12 — — CN disclosed
US-20170253576-A1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-09-07 — — US disclosed
US-20170253602-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-07 — — US disclosed
CN-103998015-B Cationic tetrahydro-pyrazole and pyridine, the dye composite comprising this kind of fouramine, its implementation and application thereof 欧莱雅 2017-09-05 — — CN disclosed
CN-107049841-A A kind of permanent type composition for hair dying 广州市花安堂生物科技有限公司 2017-08-18 — — CN disclosed
US-9730937-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-15 — — US disclosed
CN-107001298-A Cation benzo-oxazine derivative and its purposes in hair dyeing 莱雅公司 2017-08-01 — — CN disclosed
EP-3186240-A1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS Otsuka Pharmaceutical Co., Ltd. (JP) 2017-07-05 — — EP disclosed
CN-103957883-B Comprising by the pretreating agent for keratin fiber of the methyl substituted silicone of 4 morpholinyls 汉高股份有限及两合公司 2017-06-23 — — CN disclosed
CN-106795117-A Heterobicyclic compounds and their use for the treatment of tuberculosis 大塚制药株式会社 2017-05-31 — — CN disclosed
CN-106659657-A Improved decolourization of coloured keratinic fibres 汉高股份有限及两合公司 2017-05-10 — — CN disclosed
CN-103167860-B Process for producing a colorant for keratin fibres 汉高股份有限及两合公司 2017-04-26 — — CN disclosed
EP-3147281-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2017-03-29 — — EP disclosed
CN-106470668-A The improved decolouring of the keratin fiber of dyeing 汉高股份有限及两合公司 2017-03-01 — — CN disclosed
CN-106336385-A Oxadiazon synthesis method 江苏丰华化学工业有限公司 2017-01-18 — — CN disclosed
CN-106146484-A Quinazoline derivant is as RAF kinase modulator and their method and purposes 埃姆比特生物科学公司 2016-11-23 — — CN disclosed
EP-3076929-A1 MEANS FOR DYEING HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076939-A1 AGENT FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076933-A1 AGENTS FOR OXIDATIVELY DYEING HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076928-A1 COMPOSITION FOR OXIDATIVE COLOURING OF HAIR, COMPRISING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076931-A1 AGENTS FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076940-A1 AGENT FOR THE OXIDATIVE DYEING OF HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076927-A1 MEANS FOR THE OXIDATIVE DYEING OF HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3076930-A1 AGENT FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS Henkel AG & Co. KGaA (DE) 2016-10-12 — — EP disclosed
EP-3071203-A2 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS Forma Therapeutics, Inc. (US) 2016-09-28 — — EP disclosed
US-9440974-B2 Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-09-13 — — US disclosed
US-20160257692-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2016-09-08 — — US disclosed
US-20160257692-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2016-09-08 — — US disclosed
US-20160257692-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2016-09-08 — — US disclosed
US-20160256448-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2016-09-08 — — US disclosed
US-20160256448-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2016-09-08 — — US disclosed
US-20160256448-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2016-09-08 — — US disclosed
CN-105934246-A Tetrahydroquinoline compositions as BET bromodomain inhibitors 福马疗法公司 2016-09-07 — — CN disclosed
US-20160199375-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP. 2016-07-14 — — US disclosed
US-9388161-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2016-07-12 — — US disclosed
US-9388161-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2016-07-12 — — US disclosed
US-9388161-B2 Tetrahydroquinoline compositions as BET bromodomain inhibitors FORMA THERAPEUTICS, INC. (US) 2016-07-12 — — US disclosed
CN-102026985-B Quinazoline derivatives as RAF kinase modulators and methods and uses thereof 埃姆比特生物科学公司 2016-07-06 — — CN disclosed
WO-2016096449-A1 METHOD FOR MAINTAINING THE COLOUR OF DYED AND/OR HIGHLIGHTED KERATIN FIBRES HENKEL AG & CO. KGAA (DE) 2016-06-23 — — WO disclosed
WO-2016083276-A1 SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-06-02 — — WO disclosed
CN-105555251-A Multi-component packaging unit for oxidatively dyeing keratin fibers, having reduced ammonia odor HENKEL AG & CO KGAA 2016-05-04 — — CN disclosed
US-9320739-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2016-04-26 — — US disclosed
EP-3004097-A1 KINASE INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2016-04-13 — — EP disclosed
CN-105492078-A Method for evaluating hair color change UNILEVER NV 2016-04-13 — — CN disclosed
WO-2016031255-A1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-03-03 — — WO disclosed
CN-105377847-A Kinase inhibitors CHIESI FARM SPA 2016-03-02 — — CN disclosed
US-20160016953-A1 KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A (IT) 2016-01-21 — — US disclosed
CN-102665924-B Personal care composition foamed products and foaming dispenser THE PROCTER & GAMBLE CO. (US) 2015-12-02 — — CN disclosed
EP-2947072-A1 1-(3-(6,7-DIMETHOXYQUINAZOLIN-4-YLOXY)PHENYL)-3-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)UREA AS RAF KINASE MODULATOR IN THE TREATMENT OF CANCER DISEASES Ambit Biosciences Corporation (US) 2015-11-25 — — EP disclosed
CN-103153273-B Process for preparing a colorant for keratin fibres HENKEL AG & CO.KGAA (DE) 2015-11-25 — — CN disclosed
US-9181242-B2 Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2015-11-10 — — US disclosed
EP-2184285-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2015-11-04 — — EP disclosed
EP-2934684-A2 GENTLE OXIDATIVE HAIR TREATMENT WITH SPECIAL SILICONE AFTER-TREATMENT Henkel AG&Co. KGAA (DE) 2015-10-28 — — EP disclosed
EP-2934472-A2 GENTLE OXIDATIVE HAIR TREATMENT WITH SILICONE PRE-TREATMENT AND BLEACHING FORCE INTENSIFIER Henkel AG & Co. KGaA (DE) 2015-10-28 — — EP disclosed
EP-2934685-A2 GENTLE DYEING METHOD Henkel AG&Co. KGAA (DE) 2015-10-28 — — EP disclosed
US-20150299188-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-10-22 — — US disclosed
CN-103370312-B 1,3-diox-5-ketone compound MERCK PATENT GMBH (DE) 2015-09-30 — — CN disclosed
US-20150246042-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2015-09-03 — — US disclosed
CN-104876859-A Fluazuron and preparing method thereof Changzhou jialing medicine industry co ltd 2015-09-02 — — CN disclosed
US-20150232445-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2015-08-20 — — US disclosed
US-20150232445-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2015-08-20 — — US disclosed
US-20150232445-A1 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS FORMA THERAPEUTICS, INC. 2015-08-20 — — US disclosed
EP-2906191-A1 HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES Henkel AG&Co. KGAA (DE) 2015-08-19 — — EP disclosed
CN-104853735-A REDUCTION OF THE AUTOXIDATION OF AGENTS FOR THE OXIDATIVE DYEING AND/OR BLEACHING OF KERATIN FIBERS HENKEL AG & CO KGAA 2015-08-19 — — CN disclosed
EP-2399921-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2015-08-12 — — EP disclosed
CN-102655942-B Personal care composition foamed products THE PROCTER & GAMBLE CO. (US) 2015-08-12 — — CN disclosed
CN-102917683-B Porous dissolvable solid substrate and surface resident coating comprising water sensitive active THE PROCTER & GAMBLE CO. (US) 2015-08-05 — — CN disclosed
CN-104788328-A Modulators of ATP-binding cassette transporters VERTEX PHARMA 2015-07-22 — — CN disclosed
WO-2014052699-A9 AZAQUINAZOLINE INHIBITORS OF ATYPICAL PROTEIN KINASE C IGNYTA, INC. (US) 2015-07-16 — — WO disclosed
CN-104768617-A Method for straightening and dyeing hair KAO CORP 2015-07-08 — — CN disclosed
EP-2889291-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-07-01 — — EP disclosed
CN-104755465-A Heterocyclic compounds TAKEDA PHARMACEUTICAL 2015-07-01 — — CN disclosed
WO-2015082182-A1 COMPOSITION FOR OXIDATIVE COLOURING OF HAIR, COMPRISING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015082228-A1 AGENTS FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015081943-A1 AGENTS FOR OXIDATIVELY DYEING HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015082181-A1 MEANS FOR THE OXIDATIVE DYEING OF HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015082183-A1 AGENTS FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015081942-A1 AGENT FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015082227-A1 AGENT FOR OXIDATIVELY DYEING HAIR CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015081944-A1 AGENT FOR THE OXIDATIVE DYEING OF HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015082184-A1 MEANS FOR DYEING HAIR, CONTAINING SPECIFIC COMBINATIONS OF DEVELOPERS AND COUPLERS HENKEL AG & CO. KGAA (DE) 2015-06-11 — — WO disclosed
WO-2015074064-A2 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS BAIR KENNETH W (US) 2015-05-21 — — WO disclosed
WO-2015074064-A2 TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS BAIR KENNETH W (US) 2015-05-21 — — WO disclosed
EP-2268623-B1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2015-05-06 — — EP disclosed
US-9017726-B2 Biodegradable and thermosensitive poly(organophosphazene)-superparamagnetic nanoparticle complex, preparation method and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-04-28 — — US disclosed
CN-102821838-B Method for producing colorants HENKEL AG & CO KGAA 2015-03-25 — — CN disclosed
EP-2073811-B1 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS LLC (US) 2015-03-11 — — EP disclosed
CN-103130676-B Preparation method of 2-(3,4-dichloro-benzamido)-4-chlorine-5-aminophenol SHENYANG RES INST OF PHOTOGRAPHIC MATERIALS & CHEMICAL INDUSTRY 2015-03-11 — — CN disclosed
US-8969587-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2015-03-03 — — US disclosed
US-20140364412-A1 KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-12-11 — — US disclosed
WO-2014195402-A1 KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2014-12-11 — — WO disclosed
CN-102197022-B Alkyl sulfosuccinate mixtures and their use COGNIS IP MAN GMBH 2014-11-05 — — CN disclosed
CN-101891680-B Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-10-29 — — CN disclosed
CN-102639103-B Two-part hair dye KAO CORP. (JP) 2014-10-15 — — CN disclosed
CN-103998015-A Cationic tetrahydropyrazolopyridines, dye composition comprising such oxidation bases, implementation process therefor and use thereof OREAL 2014-08-20 — — CN disclosed
CN-103987368-A Zwitterionic azo dyes for dyeing keratin-containing fibres HENKEL AG & CO KGAA 2014-08-13 — — CN disclosed
CN-103957883-A Pretreatment agents for keratin fibers comprising 4-morpholino-methyl-substituted silicone(s) HENKEL AG & CO KGAA 2014-07-30 — — CN disclosed
WO-2014095181-A2 GENTLE DYEING METHOD HENKEL AG & CO. KGAA (DE) 2014-06-26 — — WO disclosed
WO-2014095179-A2 GENTLE OXIDATIVE HAIR TREATMENT WITH SILICONE PRE-TREATMENT AND BLEACHING FORCE INTENSIFIER HENKEL AG & CO. KGAA (DE) 2014-06-26 — — WO disclosed
WO-2014095182-A2 GENTLE OXIDATIVE HAIR TREATMENT WITH SPECIAL SILICONE AFTER-TREATMENT HENKEL AG & CO. KGAA (DE) 2014-06-26 — — WO disclosed
CN-103874687-A Benzodioxepin-3-one compounds as dyes or as fluorescent emitters MERCK PATENT GMBH 2014-06-18 — — CN disclosed
CN-103764111-A Dye composition comprising cationic para-aminophenol oxidation base OREAL 2014-04-30 — — CN disclosed
WO-2014056760-A1 HAIR DYE AGENT COMPRISING AMINOPYRIMIDINE DERIVATIVES HENKEL AG & CO. KGAA (DE) 2014-04-17 — — WO disclosed
US-8697874-B2 Heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-04-15 — — US disclosed
CN-103641765-A Modulators of ATP-binding cassette transporters VERTEX PHARMA 2014-03-19 — — CN disclosed
US-20140045868-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2014-02-13 — — US disclosed
CN-103547249-A Dye composition comprising at least four dye precursors including at least one oxidation base and at least one coupler OREAL 2014-01-29 — — CN disclosed
US-8618289-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2013-12-31 — — US disclosed
CN-103476391-A Oxidative hair dye or depigmenting agent composition KAO CORP 2013-12-25 — — CN disclosed
EP-2162445-B1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2013-11-27 — — EP disclosed
US-8586565-B2 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases DECIPHERA PHARMACEUTICALS, LLC (US) 2013-11-19 — — US disclosed
US-8586020-B2 Poly(organophosphazene) composition for biomaterials KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-11-19 — — US disclosed
CN-103370312-A 1,3-dioxan-5-one compounds MERCK PATENT GMBH 2013-10-23 — — CN disclosed
US-8524722-B2 Substituted tricyclic compounds and methods of use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-09-03 — — US disclosed
CN-101565381-B Method for preparing 2-alkoxy-4-amino-5-chlorobenzoic acid CHONGQING ENSKY CHEMICAL CO LTD 2013-07-24 — — CN disclosed
CN-101565381-B Method for preparing 2-alkoxy-4-amino-5-chlorobenzoic acid CHONGQING ENSKY CHEMICAL CO LTD 2013-07-24 — — CN disclosed
US-8492370-B2 Compounds and methods for their production BRISTOL-MYERS SQUIBB COMPANY (US) 2013-07-23 — — US disclosed
CN-103167861-A Process for producing a colorant HENKEL AG & CO KGAA 2013-06-19 — — CN disclosed
CN-103167860-A Process for producing a colorant for keratin fibres HENKEL AG & CO KGAA 2013-06-19 — — CN disclosed
CN-102316847-B Two-pack type hair dye product KAO CORP 2013-06-12 — — CN disclosed
CN-103153273-A Process for preparing a colorant for keratin fibres HENKEL AG & CO KGAA 2013-06-12 — — CN disclosed
CN-103121973-A Pyrimidine urea derivatives as kinase inhibitors NOVARTIS AG 2013-05-29 — — CN disclosed
CN-101553233-B Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases DECIPHERA PHARMACEUTICALS LLC 2013-05-29 — — CN disclosed
CN-103121972-A Pyrimidine urea derivatives as kinase inhibitors NOVARTIS AG 2013-05-29 — — CN disclosed
WO-2013036232-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2013-03-14 — — WO disclosed
US-8394830-B2 Quinolines and their therapeutic use PULMAGEN THERAPEUTICS (ASTHMA) LIMITED (GB) 2013-03-12 — — US disclosed
CN-101679359-B Quinolines and their therapeutic use ARGENTA DISCOVERY LTD 2013-03-06 — — CN disclosed
CN-102917683-A Porous dissolvable solid substrate and surface resident coating comprising water sensitive active PROCTER & GAMBLE 2013-02-06 — — CN disclosed
US-20130004455-A1 POLY(ORGANOPHOSPHAZENE) COMPOSITION FOR BIOMATERIALS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2013-01-03 — — US disclosed
EP-2540764-A2 Poly(organophosphazene) composition for biomaterials Korea Institute of Science and Technology (KR) 2013-01-02 — — EP disclosed
US-8344135-B2 Heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-01-01 — — US disclosed
EP-1928457-B1 QUINOLINES AND THEIR THERAPEUTIC USE PULMAGEN THERAPEUTICS ASTHMA LTD (GB) 2012-12-12 — — EP disclosed
CN-102821838-A Method for producing colorants HENKEL AG & CO KGAA 2012-12-12 — — CN disclosed
US-8313771-B2 Phosphazene hydrogels with chemical corss-link, preparation method thereof and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-11-20 — — US disclosed
US-8304557-B2 Fused heterocycle derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-11-06 — — US disclosed
EP-2212332-B1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER IP GMBH (DE) 2012-10-24 — — EP disclosed
CN-102753134-A Dyeing or bleaching kit KAO CORP 2012-10-24 — — CN disclosed
US-8273741-B2 Imidazo-pyridazinyl compounds and uses thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-09-25 — — US disclosed
CN-102665820-A Foam oxidative hair colorant compositions PROCTER & GAMBLE 2012-09-12 — — CN disclosed
CN-102665924-A Personal care composition foaming product and foaming dispenser PROCTER & GAMBLE 2012-09-12 — — CN disclosed
US-20120225057-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2012-09-06 — — US disclosed
CN-102655942-A Personal care composition foaming product PROCTER & GAMBLE 2012-09-05 — — CN disclosed
CN-102655912-A Foam hair colorant composition PROCTER & GAMBLE 2012-09-05 — — CN disclosed
WO-2012115479-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2012-08-30 — — WO disclosed
CN-101379144-B Dye and hair dyeing composition DYSTAR TEXTILFARBEN GMBH & CO 2012-08-22 — — CN disclosed
CN-102639103-A Two-part hair dye KAO CORP 2012-08-15 — — CN disclosed
WO-2012098241-A2 FIBRE-OPTIC SENSOR CITY UNIVERSITY (GB) 2012-07-26 — — WO disclosed
US-20120184579-A1 Quinolines and Their Therapeutic Use GB005, INC. 2012-07-19 — — US disclosed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 — — US disclosed
CN-102481237-A Hair dyeing method KAO CORP 2012-05-30 — — CN disclosed
CN-101646678-B heteroaryl derivatives NIPPON SHINYAKU CO LTD 2012-05-30 — — CN disclosed
US-20120121517-A1 BIODEGRADABLE AND THERMOSENSITIVE POLY(ORGANOPHOSPHAZENE)-SUPERPARAMAGNETIC NANOPARTICLE COMPLEX, PREPARATION METHOD AND USE THEREOF Korean Institute of Science and Technology of Seoul, Republic of Korea 2012-05-17 — — US disclosed
US-8173812-B2 Quinolines and their therapeutic use PULMAGEN THERAPEUTICS (ASTHMA) LIMITED (GB) 2012-05-08 — — US disclosed
EP-2013207-B1 IMIDAZO[4,5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS CANCER THERAPEUTIC COMPOUNDS CANCER REC TECH LTD (GB) 2012-04-25 — — EP disclosed
EP-2433989-A1 LIGHT-ABSORBING MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT Panasonic Corporation (JP) 2012-03-28 — — EP disclosed
EP-2129661-B1 QUINOLINE DERIVATIVES AS CRTH2 RECEPTOR LIGANDS PULMAGEN THERAPEUTICS ASTHMA LTD (GB) 2012-02-08 — — EP disclosed
CN-101316591-B Quinoline compound and pharmaceutical application thereof ARGENTA ORAL THERAPEUTICS LTD. (GB) 2012-02-01 — — CN disclosed
CN-102316847-A Two-pack type hair dye product KAO CORP 2012-01-11 — — CN disclosed
EP-2399921-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-12-28 — — EP disclosed
US-8076488-B2 Antiproliferative agents; angiogenesis inhibitors; anticancer agents BAYER HEALTHCARE LLC (US) 2011-12-13 — — US disclosed
EP-2139881-B1 QUINOLINES AND THEIR THERAPEUTIC USE PULMAGEN THERAPEUTICS ASTHMA LTD (GB) 2011-11-09 — — EP disclosed
US-8044049-B2 Fused heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-25 — — US disclosed
US-8034812-B2 Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-11 — — US disclosed
US-20110237620-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-09-29 — — US disclosed
CN-102197022-A Alkyl sulfosuccinate mixtures and their use COGNIS IP MAN GMBH 2011-09-21 — — CN disclosed
US-8003787-B2 Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors BAYER SCHERING PHARMA AG (DE) 2011-08-23 — — US disclosed
US-20110190285-A1 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT ABSOLUTE SCIENCE, INC. (US) 2011-08-04 — — US disclosed
US-20110190285-A1 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT ABSOLUTE SCIENCE, INC. (US) 2011-08-04 — — US disclosed
US-20110190285-A1 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT ABSOLUTE SCIENCE, INC. (US) 2011-08-04 — — US disclosed
US-20110160175-A1 18,21-Didesoxymacbecin Derivatives for the Treatment of Cancer MARTIN CHRISTINE 2011-06-30 — — US disclosed
EP-2337778-A1 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT Absolute Science, INC. (US) 2011-06-29 — — EP disclosed
US-20110136760-A1 Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases DECIPHERA PHARMACEUTICALS, LLC 2011-06-09 — — US disclosed
US-7951819-B2 Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2011-05-31 — — US disclosed
US-20110118245-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP. 2011-05-19 — — US disclosed
CN-101175535-B Hair waving agent SHOWA DENKO KK 2011-05-04 — — CN disclosed
CN-101460137-B One-pack type hair dye composition KAO CORP 2011-04-27 — — CN disclosed
CN-102026985-A Quinazoline derivatives as RAF kinase modulators and methods and uses thereof AMBIT BIOSCIENCES CORPORATON 2011-04-20 — — CN disclosed
CN-102014854-A Bleaching agent having cationic acyl pyridinium derivatives, co-bleaching activators, and hydrogen peroxide HENKEL AG & CO KGAA 2011-04-13 — — CN disclosed
US-20110034521-A1 COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-02-10 — — US disclosed
US-20110034521-A1 COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-02-10 — — US disclosed
US-20110034521-A1 COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-02-10 — — US disclosed
US-20110021481-A1 Novel Compounds and Methods for Their Production BRISTOL-MYERS SQUIBB COMPANY 2011-01-27 — — US disclosed
US-20110021493-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-01-27 — — US disclosed
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 — — EP disclosed
CN-101935301-A Modulators of ATP-binding cassette transporters VERTEX PHARMA 2011-01-05 — — CN disclosed
US-7858640-B2 Quinolines and their therapeutic use PULMAGEN THERAPEUTICS (ASTHMA) LIMITED (GB) 2010-12-28 — — US disclosed
US-20100297155-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS-LINK, PREPARATION METHOD THEREOF AND USE THEREOF DECA ITALIA S.R.L. (IT) 2010-11-25 — — US disclosed
CN-101891680-A The adjusting control agent of ATP- combination cassette transporters VERTEX PHARMA 2010-11-24 — — CN disclosed
US-20100273788-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-10-28 — — US disclosed
US-20100249119-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-30 — — US disclosed
US-7790756-B2 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases DECIPHERA PHARMACEUTICALS, LLC (US) 2010-09-07 — — US disclosed
EP-2212332-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2010-08-04 — — EP disclosed
EP-2211994-A2 OXIDATIVE DYEING METHOD FOR KERATINOUS FIBERS Henkel AG & Co. KGaA (DE) 2010-08-04 — — EP disclosed
US-20100168424-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-01 — — US disclosed
US-20100144787-A1 Quinolines and Their Therapeutic Use GB005, INC. 2010-06-10 — — US disclosed
US-20100144786-A1 QUINOLINE DERIVATIVES AS CRTH2 RECEPTOR LIGANDS PULMAGEN THERAPEUTICS (ASTHMA) LIMITED (GB) 2010-06-10 — — US disclosed
EP-2192957-A1 BRIGHTENING AGENT COMPRISING CATIONIC 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND HYDROGEN PEROXIDE Henkel AG & Co. KGaA (DE) 2010-06-09 — — EP disclosed
EP-2190293-A1 COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES Absolute Science, INC. (US) 2010-06-02 — — EP disclosed
CN-101715441-A Quinoline derivatives as CRTH2 receptor ligands ARGENTA DISCOVERY LTD 2010-05-26 — — CN disclosed
EP-2182915-A2 COLORING AGENT HAVING NATURAL DYES AND 1,3-DIHYDROXYACETONE Henkel AG & Co. KGaA (DE) 2010-05-12 — — EP disclosed
EP-2184285-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2010-05-12 — — EP disclosed
EP-2178492-A1 HAIR TREATMENT AGENT COMPRISING AN ACYLAMINO ACID DERIVATIVE, A HYDROXYALKYLAMINE, AND 2-(2-HYDROXYETHYL)-P-PHENYLENEDIAMINE Henkel AG & Co. KGaA (DE) 2010-04-28 — — EP disclosed
WO-2010040989-A1 QUINOLIN-2-ONE COMPOUNDS ARGENTA ORAL THERAPEUTICS LIMITED (GB) 2010-04-15 — — WO disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 — — US disclosed
CN-101686920-A Oxidation dye preparation for dyeing keratin-containing fibers using atmospheric oxygen as sole oxidizing agent HENKEL AG & CO KGAA 2010-03-31 — — CN disclosed
WO-2010033360-A1 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT 1/3 ABSOLUTE SCIENCE, INC. (US) 2010-03-25 — — WO disclosed
WO-2010033360-A1 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT 1/3 ABSOLUTE SCIENCE, INC. (US) 2010-03-25 — — WO disclosed
CN-101679359-A Quinolines and their therapeutic use ARGENTA DISCOVERY LTD 2010-03-24 — — CN disclosed
EP-2162445-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-03-17 — — EP disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 — — US disclosed
EP-2155806-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF Korea Institute of Science and Technology (KR) 2010-02-24 — — EP disclosed
EP-2152226-A2 OXIDATION DYES FOR DYEING FIBRES CONTAINING KERATIN USING ATMOSPHERIC OXYGEN AS THE ONLY OXIDATION AGENT Henkel AG & Co. KGaA (DE) 2010-02-17 — — EP disclosed
EP-2152672-A1 NOVEL SULPHOXIMINE-SUBSTITUTED QUINAZOLINE AND QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2010-02-17 — — EP disclosed
CN-101646678-A Heteroaryl Derivatives NIPPON SHINYAKU CO LTD JP 2010-02-10 — — CN disclosed
EP-2139881-A1 QUINOLINES AND THEIR THERAPEUTIC USE Argenta Oral Therapeutics Limited (GB) 2010-01-06 — — EP disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 — — EP disclosed
US-20090325945-A1 IMIDAZO[4, 5-B]PYRIDIN-2-ONE AND OXAZOLO[4, 5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS CANCER THERAPEUTIC COMPOUNDS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2009-12-31 — — US disclosed
US-20090306374-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-10 — — US disclosed
EP-2129661-A1 QUINOLINE DERIVATIVES AS CRTH2 RECEPTOR LIGANDS Argenta Oral Therapeutics Limited (GB) 2009-12-09 — — EP disclosed
CN-101565381-A Method for preparing 2-alkoxy-4-amino-5-chlorobenzoic acid CHONGQING ENSKY CHEMICAL CO LT (CN) 2009-10-28 — — CN disclosed
CN-101565381-A Method for preparing 2-alkoxy-4-amino-5-chlorobenzoic acid CHONGQING ENSKY CHEMICAL CO LT (CN) 2009-10-28 — — CN disclosed
CN-101553233-A Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases DECIPHERA PHARMACEUTICALS LLC (US) 2009-10-07 — — CN disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 — — WO disclosed
CN-101541801-A Fused heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL (JP) 2009-09-23 — — CN disclosed
US-20090226377-A1 NOVEL SULPHOXIMINE-SUBSTITUTED QUINOLINE AND QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS BAYER HEALTHCARE LLC (DE) 2009-09-10 — — US disclosed
CN-101479264-A Imidazo [4,5-B] pyridin-2-one and oxazolido [4,5-B] pyridin-2-one compounds and analogues thereof as compounds therapeutic for cancer CANCER REC TECH LTD (GB) 2009-07-08 — — CN disclosed
WO-2009080200-A1 NOVEL SULPHOXIMIDE-SUBSTITUTED QUINOLINE AND QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 — — WO disclosed
EP-2073811-A2 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES Deciphera Pharmaceuticals, LLC. (US) 2009-07-01 — — EP disclosed
US-20090163488-A1 FUSED HETEROCYCLE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 — — US disclosed
EP-2072502-A1 Sulfoximide substituted chinolin and chinazolin derivatives as kinase inhibitors Bayer Schering Pharma Aktiengesellschaft (DE) 2009-06-24 — — EP disclosed
US-20090156600-A1 Quinolines and Their Therapeutic Use GB005, INC. 2009-06-18 — — US disclosed
CN-101460137-A One-pack type hair dye composition KAO CORP (JP) 2009-06-17 — — CN disclosed
CN-101454287-A Substituted cyanopyridines as protein kinase inhibitors WYETH CORP (US) 2009-06-10 — — CN disclosed
WO-2009068330-A2 OXIDATIVE DYEING METHOD FOR KERATINOUS FIBERS HENKEL AG & CO. KGAA (DE) 2009-06-04 — — WO disclosed
CN-100493488-C Hair dye composition KAO CORP (JP) 2009-06-03 — — CN disclosed
US-20090137595-A1 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-05-28 — — US disclosed
EP-2049541-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-04-22 — — EP disclosed
WO-2009043613-A1 BRIGHTENING AGENT COMPRISING CATIONIC 3,4-DIHYDROISOQUINOLINE DERIVATIVES AND HYDROGEN PEROXIDE HENKEL AG & CO. KGAA (DE) 2009-04-09 — — WO disclosed
WO-2009045761-A1 COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES ABSOLUTE SCIENCE, INC. (US) 2009-04-09 — — WO disclosed
WO-2009045761-A1 COMPOUNDS AND METHODS FOR TREATING ZINC MATRIX METALLOPROTEASE DEPENDENT DISEASES ABSOLUTE SCIENCE, INC. (US) 2009-04-09 — — WO disclosed
CN-101394830-A Cosmetic agents comprising purine and/or purine derivatives I HENKEL KGAA (DE) 2009-03-25 — — CN disclosed
WO-2009033581-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-03-19 — — WO disclosed
WO-2009033833-A2 COLORING AGENT HAVING NATURAL DYES AND 1,3-DIHYDROXYACETONE HENKEL AG & CO. KGAA (DE) 2009-03-19 — — WO disclosed
CN-101379144-A Dye and hair dyeing composition DYSTAR TEXTILFARBEN GMBH & CO (DE) 2009-03-04 — — CN disclosed
CN-101379145-A Hair dyeing composition DYSTAR TEXTILFARBEN GMBH & CO (DE) 2009-03-04 — — CN disclosed
WO-2009024362-A1 HAIR TREATMENT AGENT COMPRISING AN ACYLAMINO ACID DERIVATIVE, A HYDROXYALKYLAMINE, AND 2-(2-HYDROXYETHYL)-P-PHENYLENEDIAMINE HENKEL AG & CO. KGAA (DE) 2009-02-26 — — WO disclosed
EP-2027093-A2 SUBSTITUTED CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS Wyeth (US) 2009-02-25 — — EP disclosed
EP-2013207-A1 IMIDAZO[4, 5-B]PYRIDIN-2-ONE AND OXAZOLO[4, 5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS CANCER THERAPEUTIC COMPOUNDS Cancer Research Technology Limited (GB) 2009-01-14 — — EP disclosed
WO-2008153278-A1 PHOSPHAZENE HYDROGELS WITH CHEMICAL CORSS -LINK, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2008-12-18 — — WO disclosed
WO-2008151858-A2 OXIDATION DYES FOR DYEING FIBRES CONTAINING KERATIN USING ATMOSPHERIC OXYGEN AS THE ONLY OXIDATION AGENT HENKEL AG & CO. KGAA (DE) 2008-12-18 — — WO disclosed
WO-2008150015-A1 HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-11 — — WO disclosed
EP-1996145-A2 REDUCTIVE COLOUR REMOVAL Henkel AG & Co. KGaA (DE) 2008-12-03 — — EP disclosed
EP-1996293-A2 REDUCTIVE COLOUR REMOVAL Henkel AG & Co. KGaA (DE) 2008-12-03 — — EP disclosed
CN-101316591-A Quinolines and their therapeutic use ARGENTA DISCOVERY LTD (GB) 2008-12-03 — — CN disclosed
WO-2008141843-A1 NOVEL SULPHOXIMINE-SUBSTITUTED QUINAZOLINE AND QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-11-27 — — WO disclosed
WO-2008122784-A1 QUINOLINES AND THEIR THERAPEUTIC USE ARGENTA DISCOVERY LIMITED (GB) 2008-10-16 — — WO disclosed
WO-2008119917-A1 QUINOLINE DERIVATIVES AS CRTH2 RECEPTOR LIGANDS ARGENTA DISCOVERY LIMITED (GB) 2008-10-09 — — WO disclosed
EP-1965754-A1 HAIR COLOURANTS Henkel AG & Co. KGaA (DE) 2008-09-10 — — EP disclosed
EP-1965753-A1 REVERSIBLY CHANGEABLE HAIR COLOR Henkel AG & Co. KGaA (DE) 2008-09-10 — — EP disclosed
EP-1962785-A1 AGENT FOR DYEING KERATIN FIBERS Henkel AG & Co. KGaA (DE) 2008-09-03 — — EP disclosed
EP-1928457-A2 QUINOLINES AND THEIR THERAPEUTIC USE Argenta Discovery Limited (GB) 2008-06-11 — — EP disclosed
CN-100393705-C Developer component and use thereof for dyeing keratin fibres HENKEL KGAA (DE) 2008-06-11 — — CN disclosed
CN-100387225-C Tabletting method of thickening system HENKEL KGAA (DE) 2008-05-14 — — CN disclosed
CN-101175535-A Hair waving agent SHOWA DENKO KK (JP) 2008-05-07 — — CN disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 — — EP disclosed
WO-2008046003-A2 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2008-04-17 — — WO disclosed
US-20080090856-A1 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS, LLC (US) 2008-04-17 — — US disclosed
CN-101155799-A Pyrimidine inhibitors of kinases TARGEGEN INC (US) 2008-04-02 — — CN disclosed
EP-1888018-A1 AGENTS FOR DYEING KERATIN-BASED FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2008-02-20 — — EP disclosed
WO-2008016192-A2 FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 — — WO disclosed
EP-1879660-A1 AGENT FOR DYEING KERATIN-BASED FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-01-23 — — EP disclosed
EP-1871486-A1 OXIDATION DYES COMPRISING PERSULFATES AND/OR PEROXODISULFATES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-01-02 — — EP disclosed
EP-1868688-A2 OXIDATION DYES COMPRISING 2-FURANONES AND COLLAGEN (DERIVATIVES) HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-12-26 — — EP disclosed
WO-2007144376-A2 LIGHTENING AND/OR DYEING AGENTS WITH ESTERS AND/OR ANHYDRIDES HENKEL AG & CO. KGAA (DE) 2007-12-21 — — WO disclosed
WO-2007146323-A2 SUBSTITUTED CYANOPYRIDINES AS PROTEIN KINASE INHIBITORS WYETH (US) 2007-12-21 — — WO disclosed
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 — — US disclosed
EP-1863794-A2 PYRIMIDINE COMPOUNDS AND METHODS OF USE Targegen, Inc. (US) 2007-12-12 — — EP disclosed
WO-2007125330-A1 IMIDAZO[4, 5-B]PYRIDIN-2-ONE AND OXAZOLO[4, 5-B]PYRIDIN-2-ONE COMPOUNDS AND ANALOGS THEREOF AS CANCER THERAPEUTIC COMPOUNDS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-11-08 — — WO disclosed
WO-2007124857-A2 LIGHTENING AND/OR DYEING AGENTS CONTAINING A PLURALITY OF FORMIC ACID ESTERS AND/OR IMIDOFORMIC ACID ESTERS HENKEL AG & CO. KGAA (DE) 2007-11-08 — — WO disclosed
WO-2007124927-A2 'LIGHTENING AND/OR COLOURING COMPOSITIONS WITH IMIDAZOLES AND AMINO ALCOHOLS' HENKEL AG & CO. KGAA (DE) 2007-11-08 — — WO disclosed
WO-2007124856-A1 OXALIC ACID-CONTAINING LIGHTENING AND/OR DYEING AGENTS HENKEL AG & CO. KGAA (DE) 2007-11-08 — — WO disclosed
EP-1838279-A1 AGENTS FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-10-03 — — EP disclosed
WO-2007107310-A2 REDUCTIVE COLOUR REMOVAL HENKEL AG & CO. KGAA (DE) 2007-09-27 — — WO disclosed
WO-2007107311-A2 ORGANIC SULPHINIC ACID DERIVATIVES HENKEL AG & CO. KGAA (DE) 2007-09-27 — — WO disclosed
WO-2007107308-A2 REDUCTIVE COLOUR REMOVAL HENKEL AG & CO. KGAA (DE) 2007-09-27 — — WO disclosed
WO-2007079793-A1 CARE HAIR-TREATMENT COMPOSITION WITH HYPERBRANCHED POLYMERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-07-19 — — WO disclosed
WO-2007079802-A1 AGENT FOR DYEING KERATIN FIBERS HENKEL AG & CO. KGAA (DE) 2007-07-19 — — WO disclosed
WO-2007073923-A1 HAIR COLOURANTS HENKEL AG & CO. KGAA (DE) 2007-07-05 — — WO disclosed
WO-2007073922-A1 REVERSIBLY CHANGEABLE HAIR COLOR HENKEL AG & CO. KGAA (DE) 2007-07-05 — — WO disclosed
EP-1796627-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-06-20 — — EP disclosed
US-7226927-B2 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. (US) 2007-06-05 — — US disclosed
EP-1789007-A1 PRODUCTS FOR DYEING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-05-30 — — EP disclosed
EP-1789014-A1 SUBSTANCE FOR DYEING KERATINIC FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-05-30 — — EP disclosed
EP-1789013-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-05-30 — — EP disclosed
EP-1778176-A2 MEANS FOR COLOURING KERATIN-CONTAINING FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2007-05-02 — — EP disclosed
EP-1776085-A1 AGENT CONTAINING AN ALKALISATION AGENT FOR LIGHTENING AND/OR COLOURING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-04-25 — — EP disclosed
WO-2007036743-A2 QUINOLINES AND THEIR THERAPEUTIC USE ARGENTA DISCOVERY LIMITED (GB) 2007-04-05 — — WO disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 — — WO disclosed
CN-1882307-A Method for dyeing fibres containing keratine HENKEL KGAA (DE) 2006-12-20 — — CN disclosed
WO-2006119819-A1 AGENT FOR DYEING KERATIN-BASED FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-11-16 — — WO disclosed
WO-2006119820-A1 AGENTS FOR DYEING KERATIN-BASED FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-11-16 — — WO disclosed
WO-2006119818-A1 AGENTS FOR DYEING KERATIN-BASED FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-11-16 — — WO disclosed
EP-1715839-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN, COMPRISING HETEROCYCLIC ENAMINES AND REACTIVE CARBONYL COMPOUNDS AND/OR REACTION PRODUCTS THEREOF Henkel Kommanditgesellschaft auf Aktien (DE) 2006-11-02 — — EP disclosed
EP-1716236-A2 ANTISENSE OLIGONUCLEOTIDES FOR TREATING UNWANTED PIGMENTATION OF THE SKIN AND HAIR Beiersdorf Aktiengesellschaft (DE) 2006-11-02 — — EP disclosed
US-20060247250-A1 Pyrimidine inhibitors of kinases TARGEGEN, INC. (US) 2006-11-02 — — US disclosed
WO-2006111255-A1 PASTE-LIKE HAIR TREATMENT AGENT COMPRISING CYCLIC CARBOXYLATE ESTERS AND SILICATES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-10-26 — — WO disclosed
WO-2006108458-A1 AGENTS FOR SIMULTANEOUSLY DYING AND LIGHTENING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-10-19 — — WO disclosed
WO-2006108505-A2 OXIDATION DYES COMPRISING 2-FURANONES AND COLLAGEN (DERIVATIVES) HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-10-19 — — WO disclosed
WO-2006108504-A1 OXIDATION DYES COMPRISING PERSULFATES AND/OR PEROXODISULFATES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-10-19 — — WO disclosed
WO-2006103036-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-10-05 — — WO disclosed
WO-2006102987-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-10-05 — — WO disclosed
WO-2006101977-A2 PYRIMIDINE COMPOUNDS AND METHODS OF USE TARGEGEN, INC. (US) 2006-09-28 — — WO disclosed
WO-2006077039-A1 AGENTS FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-07-27 — — WO disclosed
WO-2006045454-A1 AGENT COMPRISING SILYL-CARBONATE OR -CARBAMATE FOR THE SIMULTANEOUS COLOURING AND BLEACHING OF FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-05-04 — — WO disclosed
WO-2006040015-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-04-20 — — WO disclosed
CN-1761517-A Mixing device HENKEL KGAA (DE) 2006-04-19 — — CN disclosed
WO-2006032321-A1 HAIR CARE TREATMENT AGENTS CONTAINING POLYVINYL ALCOHOL HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-03-30 — — WO disclosed
WO-2006029687-A1 SUBSTANCE FOR DYEING KERATINIC FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-03-23 — — WO disclosed
WO-2006029672-A1 PRODUCTS FOR DYEING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-03-23 — — WO disclosed
WO-2006024334-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-03-09 — — WO disclosed
WO-2006018099-A1 AGENT CONTAINING AN ALKALISATION AGENT FOR LIGHTENING AND/OR COLOURING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-02-23 — — WO disclosed
WO-2005123018-A1 AGENT FOR DYEING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-12-29 — — WO disclosed
EP-1608639-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-12-28 — — EP disclosed
WO-2005120445-A2 MEANS FOR COLOURING KERATIN-CONTAINING FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-12-22 — — WO disclosed
CN-1691933-A Hair dye composition KAO CORP (JP) 2005-11-02 — — CN disclosed
CN-1681470-A Agent for dyeing keratinous fibres HENKEL KGAA (DE) 2005-10-12 — — CN disclosed
CN-1678285-A Dyeing method for porous material CIBA SC HOLDING AG (CH) 2005-10-05 — — CN disclosed
CN-1678339-A Synergistic combination of silk proteins HENKEL KGAA (DE) 2005-10-05 — — CN disclosed
EP-1575540-A1 AGENT FOR DYING KERATIN FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-09-21 — — EP disclosed
WO-2005078090-A2 ANTISENSE OLIGONUCLEOTIDES FOR TREATING UNWANTED PIGMENTATION OF THE SKIN AND HAIR BEIERSDORF AG (DE) 2005-08-25 — — WO disclosed
WO-2005063178-A1 AGENTS FOR COLOURING FIBRES CONTAINING KERATIN, COMPRISING HETEROCYCLIC ENAMINES AND REACTIVE CARBONYL COMPOUNDS AND/OR REACTION PRODUCTS THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-07-14 — — WO disclosed
EP-1351691-A4 SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA INC (US) 2005-06-22 — — EP disclosed
EP-1534227-A1 AGENTS USED FOR DYEING KERATINOUS FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-06-01 — — EP disclosed
CN-1202805-C Agent for dyeing keratin containing fibers HENKEL KGAA (DE) 2005-05-25 — — CN disclosed
CN-1196464-C Novel couplers for oxidative hair dyeing P & G CLAROR INC (US) 2005-04-13 — — CN disclosed
CN-1196463-C Solid colorant for keratin fibres HENKEL KGAA (DE) 2005-04-13 — — CN disclosed
CN-1191811-C Solid coloring agent for keratin fibers HENKEL KOMMANDIEGESELLSCHAFT A (DE) 2005-03-09 — — CN disclosed
US-20050038031-A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders BAYER HEALTHCARE LLC 2005-02-17 — — US disclosed
CN-1578771-A Developer components and their use for dyeing keratinic fibers HENKEL KGAA (DE) 2005-02-09 — — CN disclosed
CN-1182830-C Two-part hair dye compositions containing polyether polyurethanes and conditioning agents — 2005-01-05 — — CN disclosed
WO-2004078748-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 — — WO disclosed
CN-1166354-C Dyes �����ɷ� 2004-09-15 — — CN disclosed
CN-1516572-A Solid coloring agent for keratin fibers �����ɷ� 2004-07-28 — — CN disclosed
CN-1514714-A Indole/indoline based hybird dyes and indole/indoline based hybrid dye intermediate products �����ɷ� 2004-07-21 — — CN disclosed
WO-2004058200-A1 AGENT FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-07-15 — — WO disclosed
EP-1434557-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 — — EP disclosed
EP-1432388-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 — — EP disclosed
EP-1432394-A1 AGENT FOR COLORING KERATIN FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 — — EP disclosed
US-20040097503-A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2004-05-20 — — US disclosed
US-6716851-B2 ANTICANCER AGENTS CYTOVIA, INC. 2004-04-06 — — US disclosed
WO-2004022016-A1 AGENTS USED FOR DYEING KERATINOUS FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-03-18 — — WO disclosed
CN-1474682-A Enzymatic coloring agents �����ɷ� 2004-02-11 — — CN disclosed
EP-1351691-A1 SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF Cytovia, Inc. (US) 2003-10-15 — — EP disclosed
CN-1413103-A Preparation for dyeing keratin-containing fibers HENKEL KGAA (DE) 2003-04-23 — — CN disclosed
WO-2003030845-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO disclosed
WO-2003030847-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO disclosed
WO-2003030846-A1 AGENT FOR COLORING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO disclosed
CN-1411362-A Solid coloring agent for keratin fibers HENKEL KGAA (DE) 2003-04-16 — — CN disclosed
CN-1411363-A Solid coloring agent for keratin fibers HENKEL KOMMANDIEGESELLSCHAFT A (DE) 2003-04-16 — — CN disclosed
CN-1411370-A Method for tabletting thickening system HENKEL KGAA (DE) 2003-04-16 — — CN disclosed
US-20030069239-A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof CYTOVIA, INC. 2003-04-10 — — US disclosed
EP-1292269-A1 AGENT FOR DYEING KERATIN CONTAINING FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2003-03-19 — — EP disclosed
CN-1396819-A Novel couplers for oxidative hair dyeing P & G CLAROR INC (US) 2003-02-12 — — CN disclosed
WO-2002047690-A1 SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF CYTOVIA, INC. (US) 2002-06-20 — — WO disclosed
EP-1200049-A1 AGENT FOR DYING KERATIN FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2002-05-02 — — EP disclosed
WO-2001097765-A1 AGENT FOR DYEING KERATIN CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-12-27 — — WO disclosed
EP-0970148-B1 OLIGOMERIC AZO DYES BASF AG (DE) 2001-06-13 — — EP disclosed
CN-1285736-A Two-part hair dye compositions containing polyether polyurethanes and conditioning agents BRISTOL MYES SQUIBB CO (US) 2001-02-28 — — CN disclosed
WO-2001010398-A1 AGENT FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-02-15 — — WO disclosed
CN-1282317-A Novel P-aminophenol derivatives and use thereof HENKEL KGAA (DE) 2001-01-31 — — CN disclosed
CN-1281352-A Hair colorant preparation HENKEL KGAA (DE) 2001-01-24 — — CN disclosed
EP-0712903-B1 Water-soluble polyazo dyes CLARIANT GMBH (DE) 2001-01-03 — — EP disclosed
CN-1270511-A Extract and cosmetic preparation HENKEL KGAA (DE) 2000-10-18 — — CN disclosed
CN-1269714-A Use of esterquats as emulsifiers for producing preparations for dyeing keratin fibres HENKEL KOMMANDITYESELLSCHAFT A (DE) 2000-10-11 — — CN disclosed
CN-1268047-A Preservative system for personal hygiene products HENKEL KGAA (DE) 2000-09-27 — — CN disclosed
CN-1265578-A Dyes HENKEL KGAA (DE) 2000-09-06 — — CN disclosed
US-6114512-A REACTING A TETRAZOTIZED DIAMINE COMPOUND WITH A COUPLING COMPOUND CONTAINING AMINONAPHTHOL-MONO OR DI-SULFONIC ACID COMPOUND TO FORM TETRAAZO DYE BASF AKTIENGESELLSCHAFT (DE) 2000-09-05 — — US disclosed
CN-1252707-A Use of unsaturated aldehydes in dying fibers containing keratin HENKEL KGAA (DE) 2000-05-10 — — CN disclosed
CN-1248250-A Novel 1,4-diazacycloheptane derivatives and their use in hair oxidation dyes HENKEL KGAA (DE) 2000-03-22 — — CN disclosed
EP-0970148-A1 OLIGOMERIC AZO DYES BASF AKTIENGESELLSCHAFT (DE) 2000-01-12 — — EP disclosed
EP-0939754-A2 N-OXY-NAPHTHALIMIDES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1999-09-08 — — EP disclosed
US-5883282-A UREA CHEMICAL INTERMEDIATES; RICE AMERICAN CYANAMID COMPANY (US) 1999-03-16 — — US disclosed
WO-1998041581-A1 OLIGOMERIC AZO DYES BASF AKTIENGESELLSCHAFT (DE) 1998-09-24 — — WO disclosed
EP-0738764-B1 Tetrakisazo compounds, their preparation and their use as dyestuffs CLARIANT GMBH (DE) 1998-09-16 — — EP disclosed
US-5789412-A 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR ANTAGONISTS FOR THE CURATIVE OR PREVENTIVE TREATMENT OF PAIN, DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, ANXIETY OR PANIC ATTACK, OR CANCER PIERRE FABRE MEDICAMENT (FR) 1998-08-04 — — US disclosed
US-5763605-A 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents AMERICAN CYANAMID COMPANY (US) 1998-06-09 — — US disclosed
WO-1998019648-A2 N-OXY-NAPHTHALIMIDES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1998-05-14 — — WO disclosed
US-5670641-A 3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents AMERICAN CYANAMID COMPANY (US) 1997-09-23 — — US disclosed
US-5668260-A Tetrakisazo Compounds, the method of preparation thereof and the process of pyeing HOECHT AKTIENGE SELLSCHAFT (DE) 1997-09-16 — — US disclosed
US-5654256-A PREEMERGENCE, POSTEMERGENCE HERBICIDES AMERICAN CYANAMID COMPANY (US) 1997-08-05 — — US disclosed
EP-0773937-A1 NOVEL ARYL PIPERAZINE-DERIVED PIPERAZIDE DERIVATIVES, METHODS FOR THEIR PREPARATION, THEIR USE AS DRUGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME PIERRE FABRE MEDICAMENT (FR) 1997-05-21 — — EP disclosed
CN-1148592-A 3-(3-aryloxy phenylic)-1-(substituted methyl)-S-triazine-2,4,6-oxo- or sulfo-triketone herbicide AMERICAN CYANAMID CO (US) 1997-04-30 — — CN disclosed
US-5604180-A RICE CROPS AMERICAN CYANAMID COMPANY 1997-02-18 — — US disclosed
US-5597387-A BLACK DYES FOR DYEING LEATHER OR PAPER, PREPARING WRITING INKS OR RECORDING LIQUIDS HOECHST AG (DE) 1997-01-28 — — US disclosed
EP-0745595-A1 3-(3-Aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents American Cyanamid Company (US) 1996-12-04 — — EP disclosed
EP-0738764-A1 Tetrakisazo compounds, their preparation and their use as dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1996-10-23 — — EP disclosed
EP-0712903-A1 Water-soluble polyazo dyes HOECHST AKTIENGESELLSCHAFT (DE) 1996-05-22 — — EP disclosed
US-5519133-A CYCLIZATION, ALKYLATION AMERICAN CYANAMID CO. (US) 1996-05-21 — — US disclosed
WO-1996002525-A1 NOVEL ARYL PIPERAZINE-DERIVED PIPERAZIDE DERIVATIVES, METHODS FOR THEIR PREPARATION, THEIR USE AS DRUGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME PIERRE FABRE MEDICAMENT (FR) 1996-02-01 — — WO disclosed
US-5382502-A Photography, simplified synthesis EASTMAN KODAK COMPANY (US) 1995-01-17 — — US disclosed
WO-1995000109-A1 USE OF N-ALLYLAMINO AROMATICS IN OXIDATIVE DYES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1995-01-05 — — WO disclosed
EP-0331144-B1 3-SUBSTITUTED PARA-AMINO PHENOLS, PROCESS FOR THEIR PREPARATION, THEIR USE IN DYEING KERATENIC FIBRES AND INTERMEDIATES USED IN THE PREPARATION PROCESS L'OREAL (FR) 1993-06-09 — — EP disclosed
CN-1072590-A Oxidative hair dye composition and people's process for dyeing keratin fibers BRISTOL MYERS SQUIBB CO (US) 1993-06-02 — — CN disclosed
EP-0359618-B1 2-SUBSTITUTED PARA-AMINOPHENOLS AND THEIR USE IN THE COLORATION OF KERATINIC FIBRES L'OREAL (FR) 1993-03-17 — — EP disclosed
EP-0348849-B1 HAIRDYING COMPOSITION Henkel Kommanditgesellschaft auf Aktien (DE) 1992-10-14 — — EP disclosed
US-5104412-A With N-cycloalkyl-3-aminophenols as coupling compounds; colorfast brown, heat, light, chemical resistance HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1992-04-14 — — US disclosed
EP-0347283-B1 PROCESS FOR THE PREPARATION OF 2,6-DICHLORO-4-AMINOPHENOL RHONE-POULENC CHIMIE (FR) 1992-03-04 — — EP disclosed
US-5011938-A Antimicrobials ELI LILLY AND COMPANY (US) 1991-04-30 — — US disclosed
EP-0423181-A1 HAIR-DYING AGENT Henkel Kommanditgesellschaft auf Aktien (DE) 1991-04-24 — — EP disclosed
US-4976742-A LIGHTFASTNESS, WASHFASTNESS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1990-12-11 — — US disclosed
US-4940718-A BACTERICIDES ELI LILLY AND COMPANY (US) 1990-07-10 — — US disclosed
EP-0211238-B1 AMINOPHENOLS AND THEIR USE AS OXIDATION HAIR DYEING AGENTS Henkel Kommanditgesellschaft auf Aktien (DE) 1990-04-04 — — EP disclosed
EP-0359618-A1 2-Substituted para-aminophenols and their use in the coloration of keratinic fibres L'OREAL (FR) 1990-03-21 — — EP disclosed
WO-1990000046-A1 HAIR-DYING AGENT HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1990-01-11 — — WO disclosed
EP-0348849-A1 Hairdying composition Henkel Kommanditgesellschaft auf Aktien (DE) 1990-01-03 — — EP disclosed
EP-0347283-A1 Process for the preparation of 2,6-dichloro-4-aminophenol RHONE-POULENC CHIMIE (FR) 1989-12-20 — — EP disclosed
EP-0331144-A2 3-Substituted para-amino phenols, process for their preparation, their use in dyeing keratenic fibres and intermediates used in the preparation process L'OREAL (FR) 1989-09-06 — — EP disclosed
EP-0313908-A2 Halogen-substituted phenoxyphenylpropionic acid derivatives BAYER AG (DE) 1989-05-03 — — EP disclosed
EP-0150839-B1 SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL FUJI PHOTO FILM CO., LTD. (JP) 1988-09-28 — — EP disclosed
EP-0211238-A1 Aminophenols and their use as oxidation hair dyeing agents Henkel Kommanditgesellschaft auf Aktien (DE) 1987-02-25 — — EP disclosed
US-4564586-A CYAN DYE FORMING COUPLER FUJI PHOTO FILM CO., LTD. (JP) 1986-01-14 — — US disclosed
EP-0150839-A2 Silver halide color photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1985-08-07 — — EP disclosed
EP-0145513-A2 Derivatives of dimethyl-3-nitro-4-amino-aniline, process for their preparation and their use in the dyeing of keratin fibres L'OREAL (FR) 1985-06-19 — — EP disclosed
US-4357141-A FATTY ACID, BENZYL ALCOHOL, CATIONIC POLYMER L'OREAL (FR) 1982-11-02 — — US disclosed
US-4327173-A CYANINE DYE-FORMING COUPLER; HEAT RESISTANCE; PHOTOSTABILITY; COLORFASTNESS FUJI PHOTO FILM CO., LTD. (JP) 1982-04-27 — — US disclosed
US-4200466-A Light-sensitive silver halide photographic materials KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1980-04-29 — — US disclosed
US-4200466-A Light-sensitive silver halide photographic materials KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1980-04-29 — — US disclosed
Send feedback